Researchers have discovered new connections between the gut and brain that hold promise for more targeted treatments for depression and anxiety, and ...
The FDA announced that more than 233,003 bottles of duloxetine were recalled on November 19 after finding the capsules contained high levels of N-nitroso-duloxetine.